Team:Tec-Monterrey/Instructors

From 2010.igem.org

(Difference between revisions)
Line 748: Line 748:
<p class="blahimgizq">
<p class="blahimgizq">
<img src="http://2010.igem.org/wiki/images/9/9b/Drmario.jpg" alt="Dr. Mario Álvarez" />
<img src="http://2010.igem.org/wiki/images/9/9b/Drmario.jpg" alt="Dr. Mario Álvarez" />
-
Mario Moisés Álvarez is the former director of the Center for Biotechnology at Monterrey Institute of Technology and Higher Education (ITESM) in México. He is the coordinator of the Biotechnology Graduate Program at Monterrey Tech, and one of the youngest scientists in México ranked at high level by the Mexican System of Researchers, where he holds a Level 2 Researcher status. Dr. Álvarez has a Ph.D. from Rutgers University in Chemical and Biochemical Engineering, a Master on Science in Chemical Engineering from Rutgers University, another Master on Science in Process Engineering from ITESM, and a Bachelor Degree in Biochemistry from ITESM. He did a postdoctoral stay at Bristol Myers Squibb, at the Pharmaceutical Research Institute, working in different projects related to the design and scale-up of Pharmaceutical Processes, particularly reactive and crystallization processes.  
+
Mario Moisés Álvarez is the former director of the FEMSA Biotechnology Center at the Tecnológico de Monterrey in México. He is the coordinator of the Biotechnology Graduate Program in this same institution, and one of the youngest scientists in México ranked as a Level 2 Researcher by the Mexican System of Researchers (SNI). Dr. Álvarez has a Ph.D. from Rutgers University in Chemical and Biochemical Engineering, a Masters in Science in Chemical Engineering from Rutgers University, and a Masters in Science in Process Engineering and a Bachelor Degree in Biochemistry from the Tecnológico de Monterrey. He did a Postdoctoral stay at Bristol Myers Squibb, at the Pharmaceutical Research Institute, where he collaborated in different projects related to the design and scale-up of Pharmaceutical Processes, particularly reactive and crystallization processes.  
</p>
</p>
<p class="blah">
<p class="blah">
-
Dr. Álvarez main area of scientific expertise is laminar mixing (mixing operations at low speed or in high viscosity conditions). Currently, his group is working in the application of mixing knowledge on the design of bioreactors. These includes the design of novel high performance bioreactor systems for animal cell culture, the diagnosis of mixing performance in bioreactor by reactive methods, and the study of non-ideal mixing conditions in bioreactive systems.
+
Dr. Álvarez's main area of scientific expertise is laminar mixing (mixing operations at low speed or in high viscosity conditions). Currently, his group is working in the application of mixing knowledge on the design of bioreactors. This includes the design of novel high performance bioreactor systems for animal cell culture, the diagnose of mixing performance in bioreactors through reactive methods, and the study of non-ideal mixing conditions in bioreactive systems.
</p>
</p>
</div>
</div>
<div class="footercon">
<div class="footercon">
-
<h2><i>M. Sc.</i> Sergio Ángel García Echauri</h2>
+
<h2>M. Sc. Sergio Ángel García Echauri</h2>
<p class="blahimgizq">
<p class="blahimgizq">
<img src="http://2010.igem.org/wiki/images/a/a6/Sergio.jpg" alt="M. Sc. Sergio García" />
<img src="http://2010.igem.org/wiki/images/a/a6/Sergio.jpg" alt="M. Sc. Sergio García" />
-
Sergio Ángel García Echauri is a current researcher at the Center for Biotechnology at Monterrey Institute of Technology and Higher Education (ITESM) in México, where he is developing his doctorate. His early formation was in the Autonomous University of Baja California, where he obtained his title as a Biologist. Later, he carried out a thesis on the Isolation and Identification of Psychrophillic Organisms from the Antarctica and Expression of a Superoxide Dismutase from <i>Deschampsia antarctica</i> in <i>Escherichia coli</i>.
+
Sergio Ángel García Echauri is a researcher in the FEMSA Biotechnology Center at the Tecnológico de Monterrey in México, where he is currently working in his Ph.D. His early formation was in the Autonomous University of Baja California, where he obtained his title as a Biologist. He then carried out a thesis on the Isolation and Identification of Psychrophillic Organisms from the Antarctica and Expression of a Superoxide Dismutase from <i>Deschampsia antarctica</i> in <i>Escherichia coli</i>.
</p>
</p>
<p class="blah">
<p class="blah">
-
During the influenza outbreak in 2009, Sergio was part of the team that developed a novel technique for its detection and the creation of a recombinant vaccine against the A/H1N1 from cell culture. Thanks to this work, he was granted participation in the Novartis fourth annual global BioCamp, an event for the biotechnology leaders from the best universities in 27 countries from the world held at Cambridge, Massachusets in October 2009.  
+
During the influenza outbreak in 2009, Sergio was part of the team that developed a novel technique for its detection and the creation of a recombinant vaccine against the A/H1N1. He was then invited to the Novartis Fourth Annual Global BioCamp, an event for the biotechnology leaders from the best universities in 27 countries, held at Cambridge, Massachusets in October 2009.  
  </p>
  </p>
Line 776: Line 776:
</p>
</p>
<div class="footercon">
<div class="footercon">
-
<h2>Dr. Manuel Indalecio Zertuche Guerra</h2>
+
<h2>Dr. Manuel I. Zertuche Guerra</h2>
<p class="blahimgizq">
<p class="blahimgizq">
<img src="http://2010.igem.org/wiki/images/4/42/Drzertuche.jpg" alt="Dr. Manuel Zertuche" />
<img src="http://2010.igem.org/wiki/images/4/42/Drzertuche.jpg" alt="Dr. Manuel Zertuche" />
-
Text goes here.
+
Dr. Manuel Zertuche Guerra has a Masters Degree in Science with a specialization in Production Systems and a Ph.D. in Plant Physiology from Texas A&M.  In 1992, he was named the Head of the International Center for Agribusinesses and then became the Director of the Center of Strategic Studies in the Tecnológico de Monterrey. He developed strategic planning projects in Venezuela, Ecuador, Argentina, Bolivia, Nicaragua, and El Salvador. He works as a consultant and has participated in several conferences and seminars in the United States and Canada. He is currently the Head of the Biotechnology and Food Division in the Tecnológico de Monterrey and leads several research projects in collaboration with important Mexican corporations, such as FEMSA, CEMEX, LALA, Tyson, and Landsteiner Scientific.  
-
</p>
+
-
<p class="blah">
+
-
Text goes here as well.
+
</p>
</p>
</div>
</div>
<div class="footercon">
<div class="footercon">
-
<h2><i>M. Sc.</i> José Manuel Aguilar Yáñez</h2>
+
<h2>M. Sc. José Manuel Aguilar Yáñez</h2>
<p class="blahimgizq">
<p class="blahimgizq">
<img src="http://2010.igem.org/wiki/images/d/d6/Chema.jpg" alt="M. Sc. José Manuel Aguilar" />
<img src="http://2010.igem.org/wiki/images/d/d6/Chema.jpg" alt="M. Sc. José Manuel Aguilar" />
-
José Manuel Aguilar majored in Biology with specialty in Molecular Biology at the Baja California Autonomous University. In 2007, he got a Master of Science with specialty in Biotechnology at ITESM, in which he received Honorary Mention for Excelence and Outstanding Thesis Mention. He has two scientific publications and two more under revision, as well as five national patent requests and one Patent Cooperation Treaty. As of now, he works at ITESM as a professor and is on his way to finish his PhD.
+
José Manuel Aguilar majored in Biology with a specialty in Molecular Biology at the Baja California Autonomous University. In 2007, he got a M.S. Degree in Biotechnology at the Tecnológico de Monterrey, where he was awarded an Honorary Mention for Excellence and an Outstanding Thesis Mention. He has two scientific publications and two more under revision, as well as five national patent requests and one Patent Cooperation Treaty. As of now, he works at the Tecnológico de Monterrey as a professor and is on his way to finish his Ph.D.
</p>
</p>
</div>
</div>
<div class="footercon">
<div class="footercon">
-
<h2><i>M. Sc.</i> Johari Salgado Gallegos</h2>
+
<h2>M. Sc. Johari Salgado Gallegos</h2>
<p class="blahimgizq">
<p class="blahimgizq">
<img src="http://2010.igem.org/wiki/images/7/71/Johari.jpg" alt="M. Sc. Johari Salgado" />
<img src="http://2010.igem.org/wiki/images/7/71/Johari.jpg" alt="M. Sc. Johari Salgado" />
-
Text goes here
+
Johari Salgado is a biologist graduated from the Baja California Autonomous University. In 2007, he received an M.S. Degree in Biotechnology at the Tecnológico de Monterrey. He participated in the development of an Influenza vaccine during the  A/H1N1 2009 outbreak and currently leads several projects in collaboration with Landsteiner Scientific and teaches the Genetic Engineering Laboratory in the Tecnológico de Monterrey.
</p>
</p>
</div>
</div>
Line 804: Line 801:
<p class="blahimgizq">
<p class="blahimgizq">
<img src="http://2010.igem.org/wiki/images/a/a6/Sergio.jpg" alt="M. Sc. Sergio García" />
<img src="http://2010.igem.org/wiki/images/a/a6/Sergio.jpg" alt="M. Sc. Sergio García" />
-
Felipe López Pacheco has a technical degree in Biotechnology and is currently majoring in Biotechnology Engineering. As part of a joint project between the Landsteiner Pharmaceutical Group and ITESM, he is in charge of performing ELISAS to find antibodies. He is originary from Tecamac in Mexico State.
+
Felipe López Pacheco has a technical degree in Biotechnology and is currently majoring in Biotechnology Engineering. As part of a joint project between the Landsteiner Pharmaceutical Group and ITESM, he is in charge of performing ELISAS to find antibodies.
</p>
</p>
</div>
</div>

Revision as of 09:21, 27 October 2010

Tec de Monterrey





























Dr. Mario Moisés Álvarez

Dr. Mario Álvarez Mario Moisés Álvarez is the former director of the FEMSA Biotechnology Center at the Tecnológico de Monterrey in México. He is the coordinator of the Biotechnology Graduate Program in this same institution, and one of the youngest scientists in México ranked as a Level 2 Researcher by the Mexican System of Researchers (SNI). Dr. Álvarez has a Ph.D. from Rutgers University in Chemical and Biochemical Engineering, a Masters in Science in Chemical Engineering from Rutgers University, and a Masters in Science in Process Engineering and a Bachelor Degree in Biochemistry from the Tecnológico de Monterrey. He did a Postdoctoral stay at Bristol Myers Squibb, at the Pharmaceutical Research Institute, where he collaborated in different projects related to the design and scale-up of Pharmaceutical Processes, particularly reactive and crystallization processes.

Dr. Álvarez's main area of scientific expertise is laminar mixing (mixing operations at low speed or in high viscosity conditions). Currently, his group is working in the application of mixing knowledge on the design of bioreactors. This includes the design of novel high performance bioreactor systems for animal cell culture, the diagnose of mixing performance in bioreactors through reactive methods, and the study of non-ideal mixing conditions in bioreactive systems.

M. Sc. Sergio Ángel García Echauri

M. Sc. Sergio García Sergio Ángel García Echauri is a researcher in the FEMSA Biotechnology Center at the Tecnológico de Monterrey in México, where he is currently working in his Ph.D. His early formation was in the Autonomous University of Baja California, where he obtained his title as a Biologist. He then carried out a thesis on the Isolation and Identification of Psychrophillic Organisms from the Antarctica and Expression of a Superoxide Dismutase from Deschampsia antarctica in Escherichia coli.

During the influenza outbreak in 2009, Sergio was part of the team that developed a novel technique for its detection and the creation of a recombinant vaccine against the A/H1N1. He was then invited to the Novartis Fourth Annual Global BioCamp, an event for the biotechnology leaders from the best universities in 27 countries, held at Cambridge, Massachusets in October 2009.


Dr. Manuel I. Zertuche Guerra

Dr. Manuel Zertuche Dr. Manuel Zertuche Guerra has a Masters Degree in Science with a specialization in Production Systems and a Ph.D. in Plant Physiology from Texas A&M. In 1992, he was named the Head of the International Center for Agribusinesses and then became the Director of the Center of Strategic Studies in the Tecnológico de Monterrey. He developed strategic planning projects in Venezuela, Ecuador, Argentina, Bolivia, Nicaragua, and El Salvador. He works as a consultant and has participated in several conferences and seminars in the United States and Canada. He is currently the Head of the Biotechnology and Food Division in the Tecnológico de Monterrey and leads several research projects in collaboration with important Mexican corporations, such as FEMSA, CEMEX, LALA, Tyson, and Landsteiner Scientific.

M. Sc. José Manuel Aguilar Yáñez

M. Sc. José Manuel Aguilar José Manuel Aguilar majored in Biology with a specialty in Molecular Biology at the Baja California Autonomous University. In 2007, he got a M.S. Degree in Biotechnology at the Tecnológico de Monterrey, where he was awarded an Honorary Mention for Excellence and an Outstanding Thesis Mention. He has two scientific publications and two more under revision, as well as five national patent requests and one Patent Cooperation Treaty. As of now, he works at the Tecnológico de Monterrey as a professor and is on his way to finish his Ph.D.

M. Sc. Johari Salgado Gallegos

M. Sc. Johari Salgado Johari Salgado is a biologist graduated from the Baja California Autonomous University. In 2007, he received an M.S. Degree in Biotechnology at the Tecnológico de Monterrey. He participated in the development of an Influenza vaccine during the A/H1N1 2009 outbreak and currently leads several projects in collaboration with Landsteiner Scientific and teaches the Genetic Engineering Laboratory in the Tecnológico de Monterrey.

Felipe López Pacheco

M. Sc. Sergio García Felipe López Pacheco has a technical degree in Biotechnology and is currently majoring in Biotechnology Engineering. As part of a joint project between the Landsteiner Pharmaceutical Group and ITESM, he is in charge of performing ELISAS to find antibodies.